WHAT YOU NEED TO KNOW This Wednesday, the Senate Judiciary Subcommittee on Intellectual Property held a hearing on the need to strengthen patent quality and prevent the spread of low-quality and invalid patents, which have contributed in part to high drug prices. CAPA released a statement commending Sen. Tillis (R-NC) for holding this hearing and […]

Continue Reading

WHAT YOU NEED TO KNOW Thanks to the bipartisan efforts of U.S. Senators John Cornyn (R-TX) and Richard Blumenthal (D-CT), who are among those in both parties working to end Big Pharma’s exploitation of American patients, the big drug companies are on the defensive as support grows to address Big Pharma’s rampant patent abuse. On […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Michael Carrier, professor of law at Rutgers Law School and Genevieve Tung, associate director of the Rutgers Law Library, published an op-ed in Stat News on September 26 debunking Big Pharma’s disingenuous opposition of reforming the patent system. The pair encourages lawmakers to stand up to Big […]

Continue Reading

WHAT YOU NEED TO KNOW • During a recent Senate Hearing, Big Pharma and its ally, U.S. Senator Chris Coons (D-DE) continued their push for the STRONGER Patents Act, a harmful piece of legislation that would open the open the door for Big Pharma to expand their already out-of-control patent abuse. • During the same […]

Continue Reading

WHAT YOU NEED TO KNOW In case you missed it, Alex Moss with the Electronic Frontier Foundation posted a must-read rebuke of Sen. Coons’ STRONGER Patents Act. Moss’ piece details how this legislation would gut the inter partes review process – an internal process available to the Patent and Trademark Office that saves time and considerable costs […]

Continue Reading

WHAT YOU NEED TO KNOW: While Big Pharma continues to spend millions of dollars to block efforts that would help address their rampant abuse of American’s patent system, bipartisan support for patent reforms is continuing to grow. U.S. Senator John Cornyn (R-TX) has made clear ending Big Pharma’s rampant patent abuse is a critical component […]

Continue Reading

WHAT YOU NEED TO KNOW: Despite Big Pharma spending hundreds of millions of dollars on lobbyists, marketing and “legal-fortress building” as Fortune reported in a must-read piece last month, there is a growing chorus of bipartisan support in Congress for reforming the U.S. patent system.  More and more lawmakers are acknowledging that Big Pharma’s rampant […]

Continue Reading

IN CASE YOU MISSED IT: This week, the chorus of evidence and support for patent reform has grown even larger with three important news items that demonstrate both the extent of Big Pharma’s patent abuse and the much-needed relief that substantive patent reform will bring American patients. Axios published the below article yesterday keying off […]

Continue Reading

WHAT YOU NEED TO KNOW: USA Today Editorial Board: How Big Pharma Plays Games With Drug Patents And How To Combat It President Donald Trump came into office promising to do something about the inflated prices Americans pay for prescription drugs. He considered limiting rebates to the middlemen between insurance plans and drug companies but […]

Continue Reading

IN CASE YOU MISSED IT: The New York Times published the op-ed below on Saturday acknowledging the role patent abuse plays in the drug pricing crisis that faces American consumers. This op-ed reinforces what CAPA has been telling lawmakers, that Big Pharma’s abuse of the patent system is hurting patients across the nation. “There is a […]

Continue Reading